{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:38:50Z","timestamp":1758587930556,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.therap.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T22:08:39Z","timestamp":1674166119000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of coronavirus disease 2019 on contraception use in France"],"prefix":"10.1016","volume":"78","author":[{"given":"No\u00e9mie","family":"Roland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Desplas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Cuenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2023.01.002_bib0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1363\/46e9020","article-title":"Estimates of the potential impact of the COVID-19 pandemic on sexual and reproductive health in low \u2013 and middle-income countries","volume":"46","author":"Riley","year":"2020","journal-title":"Int Perspect Sex Reprod Health"},{"key":"10.1016\/j.therap.2023.01.002_bib0320","doi-asserted-by":"crossref","first-page":"020320","DOI":"10.7189\/jogh.10.020320","article-title":"Access to modern methods of contraception in Italy: Will the COVID-19 pandemic be aggravating the issue?","volume":"10","author":"Bellizzi","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/j.therap.2023.01.002_bib0325","unstructured":"OCHA. Global Humanitarian Overview 2019. 9 December 2018. https:\/\/www.unocha.org\/publication\/global-humanitarian-overview\/global-humanitarian-overview-2019.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0330","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/trstmh\/trx009","article-title":"Effect of the 2014\/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study","volume":"111","author":"Camara","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.therap.2023.01.002_bib0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/sifp.12110","article-title":"Family planning during and after the West African Ebola crisis","volume":"51","author":"Bietsch","year":"2020","journal-title":"Stud Fam Plann"},{"issue":"suppl_3","key":"10.1016\/j.therap.2023.01.002_bib0340","doi-asserted-by":"crossref","first-page":"iii32","DOI":"10.1093\/heapol\/czx108","article-title":"Counting indirect crisis-related deaths in the context of a low-resilience health system: the case of maternal and neonatal health during the Ebola epidemic in Sierra Leone","volume":"32","author":"Sochas","year":"2017","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.therap.2023.01.002_bib0345","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/1468-2346.12704","article-title":"A gendered human rights analysis of Ebola and Zika: locating gender in global health emergencies","volume":"92","author":"Davies","year":"2016","journal-title":"Int Aff"},{"key":"10.1016\/j.therap.2023.01.002_bib0350","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/OLQ.0b013e318074c5f8","article-title":"The effect of the hurricane Katrina disaster on sexual behavior and access to reproductive care for young women in New Orleans","volume":"34","author":"Kissinger","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.therap.2023.01.002_bib0355","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.contraception.2008.10.015","article-title":"Change in contraceptive methods following the Yogyakarta earthquake and its association with the prevalence of unplanned pregnancy","volume":"79","author":"Hapsari","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.therap.2023.01.002_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4269\/ajtmh.20-1269","article-title":"A Cross-sectional study of the impact of COVID-19 on domestic violence, menstruation, genital tract health, and contraception use among women in Jordan","volume":"104","author":"Aolymat","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.therap.2023.01.002_bib0365","unstructured":"Guttmacher Institute. Estimates of the potential impact of the COVID-19 pandemic on sexual and reproductive health in low- and middle-income countries. Guttmacher Institute. April 2020. https:\/\/www.guttmacher.org\/journals\/ipsrh\/2020\/04\/estimates-potential-impact-covid-19-pandemic-sexual-and-reproductive-health.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0370","unstructured":"UNFPA. Impact of the COVID-19 pandemic on family planning and ending gender-based violence, female genital mutilation and child marriage. 2020. https:\/\/www.unfpa.org\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0375","unstructured":"World Health Organization. Maintaining essential health services: operational guidance for the COVID-19 context: interim guidance. 1 June 2020. Report No.: WHO\/2019-nCoV\/essential_health_services\/2020.2. https:\/\/apps.who.int\/iris\/handle\/10665\/332240.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0380","unstructured":"World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report. 27 August 2020. Report No.: WHO\/2019-nCoV\/EHS_continuity\/survey\/2020.1. https:\/\/apps.who.int\/iris\/handle\/10665\/334048.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0385","first-page":"16","article-title":"Condom supply to global fund: an analysis of participation by Malaysian companies","volume":"15","author":"Ming","year":"2020","journal-title":"Interdiscip Res Rev"},{"key":"10.1016\/j.therap.2023.01.002_bib0390","article-title":"Opinion: how will COVID-19 affect global access to contraceptives \u2013 and what can we do about it?","author":"Purdy","year":"2020","journal-title":"Devex"},{"key":"10.1016\/j.therap.2023.01.002_bib0395","unstructured":"JOFV \u2013 Legifrance. Arr\u00eat\u00e9 du 14 mars 2020 portant diverses mesures relatives \u00e0 la lutte contre la propagation du virus COVID-19. Mar 15, 2021. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000041722917\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0400","unstructured":"JOFV \u2013 Legifrance. D\u00e9cret no\u00a02020-1310 du 29 octobre 2020 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire 2020-1310. October 29, 2020. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042475143.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0405","unstructured":"JOFV \u2013 Legifrance. D\u00e9cret no\u00a02021-16 du 9 janvier 2021 modifiant les d\u00e9crets no\u00a02020-1262 du 16 octobre 2020 et no\u00a02020-1310 du 29 octobre 2020 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire. 2021. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042896701.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0410","unstructured":"JOFV \u2013 Legifrance. D\u00e9cret no\u00a02021-384 du 2 avril 2021 modifiant les d\u00e9crets no\u00a02020-1262 du 16 octobre 2020 et no\u00a02020-1310 du 29 octobre 2020 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire. 2021. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000043327303.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0415","doi-asserted-by":"crossref","first-page":"166","DOI":"10.9745\/GHSP-D-20-00119","article-title":"Contraception in the era of COVID-19","volume":"8","author":"Nanda","year":"2020","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.therap.2023.01.002_bib0420","unstructured":"ACOG. Implementing telehealth in practice. 2020. https:\/\/www.acog.org\/en\/clinical\/clinical-guidance\/committee-opinion\/articles\/2020\/02\/implementing-telehealth-in-practice.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0425","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13625187.2020.1766016","article-title":"Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of contraception","volume":"25","author":"Fruzzetti","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.therap.2023.01.002_bib0430","unstructured":"Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and abortion care. 2020. https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/coronavirus-abortion\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0435","unstructured":"Society of Obstetricians and Gynecologists of Canada. SOGC COVID-19 resources. 2020. https:\/\/sogc.org\/covid?.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0440","doi-asserted-by":"crossref","first-page":"534","DOI":"10.9745\/GHSP-D-17-00296","article-title":"Extended effectiveness of the etonogestrel-releasing contraceptive implant and the 20 \u03bcg levonorgestrel-releasing intrauterine system for 2 years beyond U.S. food and drug administration product labeling","volume":"5","author":"Ali","year":"2017","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.therap.2023.01.002_bib0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40834-020-00114-9","article-title":"Contraception access during the COVID-19 pandemic","volume":"5","author":"Aly","year":"2020","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.therap.2023.01.002_bib0450","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmjsrh-2020-200709","article-title":"The impact of COVID-19 on contraception and abortion care policy and practice: experiences from selected countries","volume":"46","author":"Bateson","year":"2020","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.therap.2023.01.002_bib0455","unstructured":"CNGOF \u2013 National College of the French Gynecologists and Obstetricians. Activit\u00e9 de contraception en p\u00e9riode d\u2019\u00e9pid\u00e9mie. 2020. http:\/\/www.cngof.fr\/component\/rsfiles\/apercu?path=Clinique%252Freferentiels%252FCOVID-19%252FCONTRACEPTION%2B-%2BIVG%2B-%2BCOVID%252FCONTRACEPTIONCOVID.pdf&i=43096.[Accessed 24 November 2022 (3 pp.)]."},{"key":"10.1016\/j.therap.2023.01.002_bib0460","unstructured":"JOFV \u2013 Legifrance. Arr\u00eat\u00e9 du 14 avril 2020 compl\u00e9tant l\u2019arr\u00eat\u00e9 du 23 mars 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire. 2021. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000041798289\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0465","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.therap.2018.08.001","article-title":"What is pharmacoepidemiology? Definition, methods, interest and clinical applications","volume":"74","author":"Montastruc","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2023.01.002_bib0470","doi-asserted-by":"crossref","first-page":"e000104","DOI":"10.1136\/bmjmed-2021-000104","article-title":"Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study","volume":"1","author":"Bouillon","year":"2022","journal-title":"BMJ Medicine"},{"key":"10.1016\/j.therap.2023.01.002_bib0475","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.7326\/M22-0988","article-title":"Risk for myocardial infarction, stroke, and pulmonary embolism following COVID-19 vaccines in adults younger than 75 years in France","volume":"175","author":"Botton","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.therap.2023.01.002_bib0480","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamasurg.2015.1325","article-title":"Association between total hip replacement characteristics and 3-year prosthetic survivorship: a population-based study","volume":"150","author":"Colas","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.therap.2023.01.002_bib0485","unstructured":"EPI-PHARE. Covid-19\u00a0: usage des m\u00e9dicaments \u2013 rapport 6. EPI-PHARE. 2021. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/covid-19-usage-des-medicaments-rapport-6\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0490","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/AOG.0000000000004281","article-title":"Effects of the coronavirus disease 2019 (COVID-19) lockdown on the use of contraceptives and ovulation inductors in France","volume":"137","author":"Roland","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.therap.2023.01.002_bib0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2021.12.002","article-title":"Impact of coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France","volume":"108","author":"Roland","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.therap.2023.01.002_bib0500","unstructured":"JORF \u2013 Legifrance. D\u00e9cret no\u00a02016-1871 du 26 d\u00e9cembre 2016 relatif au traitement de donn\u00e9es \u00e0 caract\u00e8re personnel d\u00e9nomm\u00e9 \u00ab\u00a0syst\u00e8me national des donn\u00e9es de sant\u00e9\u00a0\u00bb. 2016-1871, JORF no\u00a00301 Dec 26, 2016. https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000033702840&categorieLien=id.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0505","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamaophthalmol.2020.5594","article-title":"Intravitreal anti-vascular endothelial growth factor use in France during the coronavirus disease 2019 pandemic","volume":"139","author":"Billioti de Gage","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.therap.2023.01.002_bib0510","doi-asserted-by":"crossref","first-page":"666848","DOI":"10.3389\/fped.2021.666848","article-title":"Mandatory infant vaccinations in France during the COVID-19 pandemic in 2020","volume":"9","author":"Taine","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.therap.2023.01.002_bib0515","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00384-020-03816-3","article-title":"Colonoscopy in France during the COVID-19 pandemic","volume":"36","author":"Meyer","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.therap.2023.01.002_bib0520","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjd.20406","article-title":"Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic","volume":"185","author":"Penso","year":"2021","journal-title":"Br J Dermatol"},{"journal-title":"Ann Rheum Dis","year":"2020","author":"Sbidian","key":"10.1016\/j.therap.2023.01.002_bib0525"},{"key":"10.1016\/j.therap.2023.01.002_bib0530","first-page":"103721","article-title":"Routine surgeries during the COVID-19 pandemic: a French nationwide cohort study","volume":"77","author":"Dufour","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.therap.2023.01.002_bib0535","unstructured":"GIS EPI-PHARE. Covid-19\u00a0: usage des m\u00e9dicaments de ville en France. EPI-PHARE. April 2020. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/usage-des-medicaments-de-ville-en-france-durant-lepidemie-de-covid-19-point-de-situation-a-la-fin-mars-2020\/.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0540","unstructured":"Rahib D, Le Guen M, Lydi\u00e9 N. Barom\u00e8tre sant\u00e9 2016. Contraception. Quatre ans apr\u00e8s la crise de la pilule, les \u00e9volutions se poursuivent. Sant\u00e9 Publique France. 2017. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/sante-sexuelle\/documents\/enquetes-etudes\/barometre-sante-2016-contraception-quatre-ans-apres-la-crise-de-la-pilule-les-evolutions-se-poursuivent.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0545","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/AOG.0000000000003646","article-title":"Telehealth interventions to improve obstetric and gynecologic health outcomes","volume":"135","author":"DeNicola","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.therap.2023.01.002_bib0550","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.contraception.2021.04.006","article-title":"Telemedicine for contraceptive counseling: patient experiences during the early phase of the COVID-19 pandemic in New York City","volume":"104","author":"Stifani","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.therap.2023.01.002_bib0555","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1186\/s12889-020-10048-1","article-title":"The French general population's attitudes toward lockdown against COVID-19: a fragile consensus","volume":"20","author":"Peretti-Watel","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.therap.2023.01.002_bib0560","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1056\/NEJMp2008006","article-title":"Abortion during the Covid-19 pandemic \u2013 ensuring access to an essential health service","volume":"382","author":"Bayefsky","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2023.01.002_bib0565","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.contraception.2021.02.001","article-title":"The impact of the COVID-19 pandemic on economic security and pregnancy intentions among people at risk of pregnancy","volume":"103","author":"Lin","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.therap.2023.01.002_bib0570","unstructured":"DRESS. Interruptions volontaires de grossesse\u00a0: une l\u00e9g\u00e8re baisse du taux de recours en 2020 | Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques. September 2021. https:\/\/drees.solidarites-sante.gouv.fr\/publications\/etudes-et-resultats\/interruptions-volontaires-de-grossesse-une-legere-baisse-du-taux.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0575","unstructured":"INSEE. Bilan d\u00e9mographique 2020 \u2013 Insee Premi\u00e8re \u2013 1834. 2021. https:\/\/www.insee.fr\/fr\/statistiques\/5012724.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0580","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625187.2021.1884221","article-title":"Contraceptive use and pregnancy plans among women of reproductive age during the first Australian COVID-19 lockdown: findings from an online survey","volume":"26","author":"Coombe","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.therap.2023.01.002_bib0585","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijgo.13193","article-title":"Effect of the COVID-19 pandemic on female sexual behavior","volume":"150","author":"Yuksel","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.therap.2023.01.002_bib0590","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.sexol.2020.08.002","article-title":"Les impacts du confinement li\u00e9 au coronavirus sur la sexualit\u00e9","volume":"29","author":"Landry","year":"2020","journal-title":"Sexologies"},{"key":"10.1016\/j.therap.2023.01.002_bib0595","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s13178-020-00506-1","article-title":"\u201cINSIDE\u201d project on sexual health in Spain: sexual life during the lockdown caused by COVID-19","volume":"18","author":"Ballester-Arnal","year":"2021","journal-title":"Sex Res Social Policy"},{"key":"10.1016\/j.therap.2023.01.002_bib0600","doi-asserted-by":"crossref","first-page":"565823","DOI":"10.3389\/fpsyg.2020.565823","article-title":"Changes in sexuality and quality of couple relationship during the COVID-19 lockdown","volume":"11","author":"Panzeri","year":"2020","journal-title":"Front Psychol"},{"key":"10.1016\/j.therap.2023.01.002_bib0605","doi-asserted-by":"crossref","first-page":"e0248072","DOI":"10.1371\/journal.pone.0248072","article-title":"COVID-19 lockdowns and demographically-relevant google trends: a cross-national analysis","volume":"16","author":"Berger","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2023.01.002_bib0610","unstructured":"Lambert A., Cayouette-Rembli\u00e8re J., Gu\u00e9raut E., Le Roux G., Bonvalet C., Girad V., et al. How the COVID-19 epidemic changed working conditions in France. Ined \u2013 Institut national d\u2019\u00e9tudes d\u00e9mographiques; 2020. [https:\/\/www.ined.fr\/en\/publications\/editions\/population-and-societies\/the-work-and-its-facilitieswhat-covid-19-has-changed-for-french-people\/. Accessed 24 November 2022]"},{"key":"10.1016\/j.therap.2023.01.002_bib0615","unstructured":"UNSDG. Policy brief: the impact of COVID-19 on women. 2021. https:\/\/unsdg.un.org\/resources\/policy-brief-impact-covid-19-women.[Accessed 24 November 2022]."},{"key":"10.1016\/j.therap.2023.01.002_bib0620","unstructured":"French National Agency for the Safety of Medicines and Health Products. Dossier th\u00e9matique \u2013 Contraception \u2013 ANSM. 202. https:\/\/ansm.sante.fr\/dossiers-thematiques\/contraception.[Accessed 24 November 2022]."}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:36Z","timestamp":1758567396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595723000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0040595723000185"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2023.01.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of coronavirus disease 2019 on contraception use in France","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}